Survival benefit of transarterial chemoinfusion for patients with far advanced hepatocellular carcinoma

被引：0
|
作者：
Kang, Mun Su [1 ]
Oh, Se Yong [1 ]
Cho, Yong Kyun [1 ]
Kim, Byung Ik [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A51 / A51
页数：1
相关论文
共 50 条
  • [1] TRANSARTERIAL CHEMOEMBOLIZATION PROVIDES SURVIVAL BENEFIT IN PATIENTS WITH SPONTANEOUSLY RUPTURED HEPATOCELLULAR CARCINOMA
    Lee, J. S.
    Oh, D. -H.
    Lee, H.
    Bae, W.
    Kim, N. -H.
    Kim, K. -A.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S259 - S259
  • [2] TRANSARTERIAL CHEMOEMBOLIZATION COULD ACHIEVED A SURVIVAL BENEFIT IN SELECTED PATIENTS WHO HAVE ADVANCED STAGE OF HEPATOCELLULAR CARCINOMA
    Kim, Ji Hoon
    Jung, Young Kul
    Choi, Jong Hwan
    Kim, Chung Ho
    Kim, Jeong Han
    Yeon, Jong Eun
    Yim, Hyung Joon
    Byun, Kwan Soo
    HEPATOLOGY, 2008, 48 (04) : 962A - 963A
  • [3] Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience
    Bettinger, Dominik
    Spode, Renan
    Glaser, Nicolas
    Buettner, Nico
    Boettler, Tobias
    Neumann-Haefelin, Christoph
    Brunner, Thomas Baptist
    Gkika, Eleni
    Maruschke, Lars
    Thimme, Robert
    Schultheiss, Michael
    BMC GASTROENTEROLOGY, 2017, 17
  • [4] Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience
    Dominik Bettinger
    Renan Spode
    Nicolas Glaser
    Nico Buettner
    Tobias Boettler
    Christoph Neumann-Haefelin
    Thomas Baptist Brunner
    Eleni Gkika
    Lars Maruschke
    Robert Thimme
    Michael Schultheiss
    BMC Gastroenterology, 17
  • [5] Transarterial Chemoembolization related to Good Survival for Selected Patients with advanced Hepatocellular Carcinoma
    Le, Yong
    Shen, Jing-Xian
    Zhang, Yong-Fa
    He, Min-Ke
    Kan, Anna
    Chen, Hai-Long
    Yu, Zi-Shan
    Li, Qi-Jiong
    Shi, Ming
    JOURNAL OF CANCER, 2019, 10 (03): : 665 - 671
  • [6] Sorafenib combined with transarterial chemoembolization prolongs survival of patients with advanced hepatocellular carcinoma
    Liu, Quanguo
    Dai, Yajie
    JOURNAL OF BUON, 2020, 25 (02): : 945 - 951
  • [7] Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation
    De Luna, W.
    Sze, D. Y.
    Ahmed, A.
    Ha, B. Y.
    Ayoub, W.
    Keeffe, E. B.
    Cooper, A.
    Esquivel, C.
    Nguyen, M. H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) : 1158 - 1168
  • [8] Transarterial chemoembolization in patients with hepatocellular carcinoma: Predictors of survival
    Sawhney, Summit
    Montano-Loza, Aldo J.
    Salat, Peter
    McCarthy, Mairin
    Kneteman, Norman
    Meza-Junco, Judith
    Owen, Richard
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2011, 25 (08): : 426 - 432
  • [9] Significant Survival Benefit from Transarterial Chemoembolization As Palliative Therapy for Hepatocellular Carcinoma
    Meister, Tobias
    Heinzow, Hauke
    Nass, Dominik
    Koehler, Michael
    Ullerich, Hansjoerg
    Domschke, Wolfram W.
    Domagk, Dirk
    GASTROENTEROLOGY, 2009, 136 (05) : A479 - A479
  • [10] The Impact of Combined Transarterial Chemoembolization on the Overall Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
    Chen, Lufeng
    Su, Hongying
    Shao, Haibo
    Xu, Ke
    Liang, Songnian
    Liu, Ling
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 802 - 808
12345